0000000000522691

AUTHOR

Eugen Davids

showing 9 related works from this author

Evaluation eines standardisierten Trainings für die "Positive and Negative Syndrome Scale" (PANSS)

2000

Die vorliegende Arbeit umfasst 3 Untersuchungen zur Interrater-Reliabilitat der deutschen Version der “Positive and Negative Syndrome Scale for Schizophrenia” (PANSS). Zur Interrater-Reliabilitat und Trainierbarkeit der PANSS liegen im deutschen Sprachraum trotz der weiten Verbreitung der Skala bisher keine empirischen Daten vor. Bei 3 Stichproben mit insgesamt 47 Teilnehmern unterschiedlicher klinischer Erfahrung wurde ein standardisiertes PANSS-Rater-Training durchgefuhrt und evaluiert. Als Qualitatsmase fur das Training wurden die Ubereinstimmung mit einem Expertenstandard (K) und gewichtete Kappa-Koeffizienten (κw) berechnet. Als ein Hauptergebnis lasst sich feststellen, dass zur Erreic…

GynecologyPsychiatry and Mental healthmedicine.medical_specialtyPsychotherapistNeurologyPositive and Negative Syndrome ScalemedicineNeurology (clinical)General MedicineRater trainingPsychologyDer Nervenarzt
researchProduct

Psychopharmakotherapie in Schwangerschaft und Stillzeit

1998

The primary purpose of this article is to review critically the literature on the use of psychotropic medications in pregnancy and during breast feeding in order to suggest strategies for the clinical management of these periods. Use of psychotropic medications during pregnancy may cause three complications: 1. teratogenicity, 2. perinatal syndromes (neonatal toxicity), and 3. postnatal behavioural sequelae (behavioural toxicity). The literature features few well-controlled studies concerning these points, so that the available information allows only few conclusions. Exposure to certain psychotropic drugs in utero may increase the risk for some specific congenital anomalies; there is mostl…

Pediatricsmedicine.medical_specialtyPregnancyDrug discontinuationbusiness.industryBehavioural toxicitymedicine.diseasePsychiatry and Mental healthNeurologyPsychotropic drug useToxicitymedicineNeurology (clinical)Relapse riskbusinessBreast feedingFortschritte der Neurologie · Psychiatrie
researchProduct

Syndrome profiles in alcoholism and panic disorder with or without agoraphobia

2002

It is proposed that alcoholism and panic disorder/agoraphobia demonstrate in part common genetic and environmental origins. Shared subthreshold symptom patterns in the parents' generation could confirm the proposed genetic role in alcoholism and panic disorder/agoraphobia, even if the parents do not fulfil the diagnostic criteria for a primary psychiatric diagnosis. This is the first family study of exploratively analyzing subthreshold symptoms in both disorders. The authors investigated families with panic disorder/agoraphobia and/or alcoholism with the Munich-Composite International Diagnostic Interview (M-CIDI). We documented the diagnoses according to Diagnostic and Statistical Manual o…

PharmacologyProbandmedicine.medical_specialtyAddictionmedia_common.quotation_subjectPanic disorderPanicICD-10medicine.diseasebehavioral disciplines and activitieshumanitiesmental disordersmedicineAnxietymedicine.symptomPsychologyPsychiatryBiological PsychiatryAnxiety disordermedia_commonClinical psychologyAgoraphobiaProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Dysarthria and Pathological Laughter/Crying as Presenting Symptoms of Corticobasal- Ganglionic Degeneration Syndrome

2003

Pathological laughterDysarthriamedicine.medical_specialtyNeurologyNeurologyCryingmedicineNeurology (clinical)Degeneration (medical)medicine.symptomAudiologyPsychologyNeuroradiologyJournal of Neurology
researchProduct

Relationship of Psychiatric Experience and Interrater Reliability in Assessment of Negative Symptoms

1999

AdultMalePsychosismedicine.medical_specialtyPsychometricsPsychometricsmedicineHumansPsychiatryPsychiatric Status Rating ScalesPsychiatryNegative symptomTeachingReproducibility of ResultsVideotape RecordingMiddle Agedmedicine.diseasePsychiatry and Mental healthInter-rater reliabilitySchizophreniaSchizophreniaEducation Medical ContinuingFemaleSchizophrenic PsychologyClinical CompetencePsychologyClinical psychologyThe Journal of Nervous & Mental Disease
researchProduct

Medikamente zur Behandlung von Persönlichkeitsstörungen

1998

Die Therapie von Personlichkeitsstorungen war lange Zeit ausschlieslich eine Domane psychotherapeutischer Interventionen. Mittlerweile existieren einige kontrollierte Studien auch zum Einsatz von Psychopharmaka bei Personlichkeitsstorungen Die Ergebnisse sind aber fur allgemeine Empfehlungen noch zu wenig abgesichert. Die Diagnose von Personlichkeitsstorungen (z. B. Achse-Il-Storungen nach DSM-IV) ist fehleranfallig. Die diagnostischen Kategorien sind uneinheitlich und derzeit noch im Flus; selbst strukturierte Interviews erfahrener Untersucher zeigen nur begrenzte Verlaslichkeit. Wichtig ist die Erfassung und — wenn moglich — Abgrenzung von gleichzeitig vorhandenen Achse-I-Storungen nach D…

researchProduct

Medikamente zur Phasenprophylaxe affektiver Psychosen und zur Behandlung manischer Syndrome

1998

Folgende Substanzgruppen sind in der Therapie manischer Syndrome und/oder in der Phasenprophylaxe affektiver Storungen etabliert (Im folgenden werden die Begriffe affektive bzw. schizoaffektive „Storung“ bzw. „Psychose“ weitgehend synonym verwendet.)

researchProduct

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo

2003

Udgivelsesdato: 2003-Apr The antipsychotic effect of neuroleptics cannot be attributed entirely to acute blockade of postsynaptic D(2)-like dopamine (DA) receptors, but may arise in conjunction with the delayed depolarization block of the presynaptic neurons and reduced DA synthesis capacity. Whereas the phenomenon of depolarization block is well established in animals, it is unknown if a similar phenomenon occurs in humans treated with neuroleptics. We hypothesized that haloperidol treatment should result in decreased DA synthesis capacity. We used 6-[(18)F]fluoro-L-dopa (FDOPA) and positron emission tomography (PET) in conjunction with compartmental modeling to measure the relative activi…

AdultMalePsychosismedicine.medical_specialtyPatientsDopamineDown-RegulationStatistics NonparametricDopamineInternal medicinemedicineHaloperidolHumansPharmacologybusiness.industryPutamenDopamine antagonistBrainDepolarizationHuman brainMiddle Agedmedicine.diseasePsychiatry and Mental healthEndocrinologymedicine.anatomical_structureCerebral cortexAnesthesiaSchizophreniaHaloperidolbusinessTomography Emission-Computedmedicine.drug
researchProduct

Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors

2002

The preservation of the neuronal circuitry in rat cerebellar slice cultures provides an advantage in monitoring the development and characterizing the pharmacology of GABA(A) receptor subtypes. Sprague-Dawley rats, 8-11 days of age, were decapitated, their cerebella were cut into 400-microm slices and transferred into culture dishes. Cell viability and organotypic cerebellar organization of the culture remained well preserved up to 3 weeks. Autoradiographic procedures were introduced in these advanced culture technique and employed [(3)H]Ro 15-4513 in the absence and presence of 10 microM diazepam to visualize all benzodiazepine (BZD) and diazepam-insensitive (DIS) binding sites, respective…

MaleAgonistAzidesCerebellumCell Survivalmedicine.drug_classProtein subunitBiologyPharmacologyRats Sprague-DawleyBenzodiazepinesCerebellumCulture TechniquesmedicineAnimalsPharmacology (medical)Viability assayReceptorCells CulturedBiological PsychiatryPharmacologyBenzodiazepineBinding SitesGABAA receptorAffinity LabelsReceptors GABA-ARatsPsychiatry and Mental healthmedicine.anatomical_structureAnimals NewbornNeurologyOrgan SpecificityNeurology (clinical)NeuroscienceDiazepammedicine.drugEuropean Neuropsychopharmacology
researchProduct